Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer

Journal of the American College of Surgeons

Volumn 191, Issue 6, 2000, Pages 593-599

  Olson Jr, John A ^a   Fey, Jane ^a   Winawer, Joanna ^a   Borgen, Patrick I ^a   Cody III, Hiram S ^a   Van Zee, Kimberly J ^a   Petrek, Jeanne ^a   Heerdt, Alexandra S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ACCURACY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL EXAMINATION; FEMALE; HUMAN; IMAGING; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; AXILLA; BREAST NEOPLASMS; DECISION TREES; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE CARE; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; PALPATION; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0034532135     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(00)00732-8     Document Type: Article

References (27)

1. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: A study of 644 patients with median follow-up of 18 years
2. Axillary node dissection for early breast cancer: Some is good, but all is better
3. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma
4. Axillary dissection: An obsolete operation?
5. Is axillary lymph node dissection necessary in routine management of breast cancer?
6. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
7. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
8. Sentinel lymph node mapping in breast cancer
9. Sentinel node biopsy in breast cancer
10. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
11. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
12. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
13. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
14. Sentinel lymph node biopsy for breast cancer - Not yet the standard of care
15. A plea for the pathologically accurate sentinel node
16. Sentinel node update: Breast cancer
17. Credentialing for breast lymphatic mapping: How many cases are enough?
18. Lessons learned from 500 cases of lymphatic mapping for breast cancer
19. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients
20. Sentinel lymph node biopsy in breast cancer: Unfiltered radioisotope is superior to filtered
21. Pathological findings from the NSABP protocol 4: Discriminate for tenth year treatment failure
22. Axillary dissection: Current practice and technique
23. The impact of prophylactic axillary node dissection on breast cancer survival - A Bayesian meta-analysis
24. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast
25. Level I and II axillary dissection in the treatment of early-stage breast cancer
26. The sentinel node in breast cancer - A multicenter validation study
27. Update: NCCN practice guidelines for the treatment of breast cancer